Neoplasm malignant and Periorbital cellulitis

Summary:

Periorbital cellulitis is found among people with Neoplasm malignant, especially for people who are female, 10-19 old.

The study analyzes which people have Periorbital cellulitis with Neoplasm malignant. It is created by eHealthMe based on reports of 16 people who have Neoplasm malignant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Neoplasm malignant?

Neoplasm malignant (cancer tumour) is found to be associated with 1,537 drugs and 1,261 conditions by eHealthMe. Check the latest studies of Neoplasm malignant.

What is Periorbital cellulitis?

Periorbital cellulitis (inflammation and infection of the eyelid and the skin surrounding the eye) is found to be associated with 102 drugs and 344 conditions by eHealthMe. Check the latest studies of Periorbital cellulitis.



On Jul, 08, 2026

16 people who have Neoplasm Malignant and Periorbital Cellulitis are studied.

Would you have Periorbital cellulitis when you have Neoplasm malignant?

Gender of people who have Neoplasm Malignant and experienced Periorbital Cellulitis *:

  • female: 93.75 %
  • male: 6.25 %

Age of people who have Neoplasm Malignant and experienced Periorbital Cellulitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 90 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 10 %

Common co-existing conditions for these people *:

  1. Pain: 9 people, 56.25%
  2. Mucosal Inflammation (infection of mucous membrane): 9 people, 56.25%
  3. Menstrual Disorder (disease of menstrual cycle): 9 people, 56.25%
  4. Infection: 9 people, 56.25%
  5. Device Related Infection: 9 people, 56.25%
  6. Haemoglobin Decreased: 8 people, 50.00%
  7. Constipation: 8 people, 50.00%
  8. Anaesthesia: 7 people, 43.75%
  9. Osteoporosis (bones weak and more likely to break): 7 people, 43.75%
  10. Nausea (feeling of having an urge to vomit): 4 people, 25.00%

Common drugs taken by these people *:

  1. Fentanyl: 13 people, 81.25%
  2. Oxycodone: 10 people, 62.50%
  3. Paracetamol: 9 people, 56.25%
  4. Heparin: 9 people, 56.25%
  5. Codeine: 9 people, 56.25%
  6. Ondansetron: 8 people, 50.00%
  7. Zyrtec: 7 people, 43.75%
  8. Gemzar: 7 people, 43.75%
  9. Faslodex: 7 people, 43.75%
  10. Dexamethasone Sodium Phosphate: 7 people, 43.75%

Common symptoms for these people *:

  1. Constipation: 10 people, 62.50%
  2. Vena Cava Thrombosis (clotting of the blood in large vein carrying deoxygenated blood into the heart): 9 people, 56.25%
  3. Diarrhea: 9 people, 56.25%
  4. Haemoglobin Decreased: 9 people, 56.25%
  5. Febrile Neutropenia (fever with reduced white blood cells): 9 people, 56.25%
  6. Vitreous Floaters (spots before the eyes): 7 people, 43.75%
  7. Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 7 people, 43.75%
  8. Eye Allergy: 7 people, 43.75%
  9. Eye Pain: 7 people, 43.75%
  10. Eye Swelling: 7 people, 43.75%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Periorbital cellulitis?

- Check whether Periorbital cellulitis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Periorbital cellulitis:

All the conditions that are associated with Periorbital cellulitis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Periorbital cellulitis and Neoplasm malignant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: